Literature DB >> 2512009

Free radicals and cardioplegia: organic anti-oxidants as additives to the St Thomas' Hospital cardioplegic solution.

D J Chambers1, G Astras, A Takahashi, A S Manning, M V Braimbridge, D J Hearse.   

Abstract

The isolated perfused working rat heart model of cardiopulmonary bypass and ischaemic cardiac arrest has been used to investigate whether addition of various organic anti-oxidants to the St Thomas' Hospital cardioplegic solution can enhance the recovery of function of the rat myocardium after normothermic (37 degrees C) global ischaemic arrest. Five anti-oxidants were studied: (i) ascorbate (1.0 and 10.0 mmol.litre-1), (ii) methionine (1.0 and 10.0 mmol.litre-1), (iii) reduced glutathione (1.0 and 10.0 mmol.litre-1), (iv) dimethylthiourea (0.1, 1.0, 10.0 and 50.0 mmol.litre-1), (v) N-2-mercaptopropionyl glycine (0.1, 1.0 and 10.0 mmol.litre-1). The recovery of aortic flow in control hearts which were free of anti-oxidant was 50.7(SEM 0.5)%; ascorbate (1.0 or 10.0 mmol.litre-1) improved this recovery to 72.1(1.7) and 70.2(0.3)% respectively; methionine (1.0 and 10.0 mmol.litre-1) improved the recovery to 74.1(5.7)% and 67.7(1.7)%, respectively; reduced glutathione (1.0 and 10.0 mmol.litre-1) improved the recovery to 66.7(1.4)% and 74.0(1.7)% respectively. In further studies, the addition of dimethylthiourea (0.1, 1.0 and 10.0 mmol.litre-1) to the cardioplegic solution failed to improve recovery of aortic flow [47.3(8.0), 24.6(7.3), 48.0(7.7)% respectively] when compared to its anti-oxidant free control value of 40.4(6.1)% and at a concentration of 50.0 mmol.litre-1 a very poor recovery of aortic flow of 7.7(4.8)% was observed. Mercaptopropionyl glycine (0.1, 1.0 and 10.0 mmol.litre-1) also failed to improve the recovery of aortic flow [34.7(1.6), 34.7(7.7) and 25.6(5.4)% respectively.2+ Since biological membranes are highly permeable to dimethylthiourea and mercaptopropionyl glycine, it is possible that they accumulate in the intracellular compartment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512009     DOI: 10.1093/cvr/23.4.351

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  Lipid peroxidation during myocardial reperfusion.

Authors:  C Ceconi; A Cargnoni; E Pasini; E Condorelli; S Currello; R Ferrari
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

Review 2.  Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection.

Authors:  Qin Yang; Guo-Wei He; Malcolm John Underwood; Cheuk-Man Yu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 3.  Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.

Authors:  Andrew M Walters; George A Porter; Paul S Brookes
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

Review 4.  Stunning: a radical re-view.

Authors:  D J Hearse
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

5.  Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution.

Authors:  Sarkis M Minasian; Michael M Galagudza; Yuri V Dmitriev; Dmitry I Kurapeev; Timur D Vlasov
Journal:  J Cardiothorac Surg       Date:  2013-04-02       Impact factor: 1.637

6.  Effect of Ginkgo biloba extract 50 on immunity and antioxidant enzyme activities in ischemia reperfusion rats.

Authors:  Shaoping Lu; Xia Guo; Pinting Zhao
Journal:  Molecules       Date:  2011-11-02       Impact factor: 4.411

Review 7.  Oxidative Stress after Surgery on the Immature Heart.

Authors:  Daniel Fudulu; Gianni Angelini
Journal:  Oxid Med Cell Longev       Date:  2016-03-31       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.